Literature DB >> 25045521

Novel gemini cationic lipids with carbamate groups for gene delivery.

Yi-Nan Zhao1, Farooq Qureshi2, Shu-Biao Zhang3, Shao-Hui Cui3, Bing Wang3, Hui-Ying Chen3, Hong-Tao Lv4, Shu-Fen Zhang5, Leaf Huang6.   

Abstract

To obtain efficient non-viral vectors, a series of Gemini cationic pan class="Chemical">lipids with n>an class="Chemical">carbamate linkers between headgroups and hydrophobic tails were synthesized. They have the hydrocarbon chains of 12, 14, 16 and 18 carbon atoms as tails, designated as G12, G14, G16 and G18, respectively. These Gemini cationic lipids were prepared into cationic liposomes for the study of the physicochemical properties and gene delivery. The DNA-bonding ability of these Gemini cationic liposomes was much better than their mono-head counterparts (designated as M12, M14, M16 and M18, respectively). In the same series of liposomes, bonding ability declined with an increase in tail length. They were tested for their gene-transferring capabilities in Hep-2 and A549 cells. They showed higher transfection efficiency than their mono-head counterparts and were comparable or superior in transfection efficiency and cytotoxicity to the commercial liposomes, DOTAP and Lipofectamine 2000. Our results convincingly demonstrate that the gene-transferring capabilities of these cationic lipids depended on hydrocarbon chain length. Gene transfection efficiency was maximal at a chain length of 14, as G14 can silence about 80 % of luciferase in A549 cells. Cell uptake results indicate that Gemini lipid delivery systems could be internalised by cells very efficiently. Thus, the Gemini cationic lipids could be used as synthetic non-viral gene delivery carriers for further study.

Entities:  

Year:  2014        PMID: 25045521      PMCID: PMC4100725          DOI: 10.1039/C3TB21506G

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  34 in total

1.  Gene delivery using dendrimer-entrapped gold nanoparticles as nonviral vectors.

Authors:  Yuebin Shan; Ting Luo; Chen Peng; Ruilong Sheng; Amin Cao; Xueyan Cao; Mingwu Shen; Rui Guo; Helena Tomás; Xiangyang Shi
Journal:  Biomaterials       Date:  2012-01-15       Impact factor: 12.479

Review 2.  Peptide-based cationic liposome-mediated gene delivery.

Authors:  Yinan Zhao; Shubiao Zhang; Shaohui Cui; Bing Wang; Shufen Zhang
Journal:  Expert Opin Drug Deliv       Date:  2011-11-22       Impact factor: 6.648

Review 3.  Cationic lipids and polymers mediated vectors for delivery of siRNA.

Authors:  Shubiao Zhang; Budiao Zhao; Huiming Jiang; Bing Wang; Baichao Ma
Journal:  J Control Release       Date:  2007-08-07       Impact factor: 9.776

Review 4.  Hybrids of nonviral vectors for gene delivery.

Authors:  Shubiao Zhang; Yinan Zhao; Budiao Zhao; Bing Wang
Journal:  Bioconjug Chem       Date:  2010-06-16       Impact factor: 4.774

5.  Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery.

Authors:  I van der Woude; A Wagenaar; A A Meekel; M B ter Beest; M H Ruiters; J B Engberts; D Hoekstra
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

6.  Diaminododecane-based cationic bolaamphiphile as a non-viral gene delivery carrier.

Authors:  Majad Khan; Chung Yen Ang; Nikken Wiradharma; Lin-Kin Yong; Shaoqiong Liu; Lihong Liu; Shujun Gao; Yi-Yan Yang
Journal:  Biomaterials       Date:  2012-03-21       Impact factor: 12.479

Review 7.  Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises.

Authors:  Priya Prakash Karmali; Arabinda Chaudhuri
Journal:  Med Res Rev       Date:  2007-09       Impact factor: 12.944

8.  A novel cationic lipophosphoramide with diunsaturated lipid chains: synthesis, physicochemical properties, and transfection activities.

Authors:  Tony Le Gall; Damien Loizeau; Erwan Picquet; Nathalie Carmoy; Jean-Jacques Yaouanc; Laure Burel-Deschamps; Pascal Delépine; Philippe Giamarchi; Paul-Alain Jaffrès; Pierre Lehn; Tristan Montier
Journal:  J Med Chem       Date:  2010-02-25       Impact factor: 7.446

Review 9.  Lipoplex structures and their distinct cellular pathways.

Authors:  Kai Ewert; Heather M Evans; Ayesha Ahmad; Nelle L Slack; Alison J Lin; Ana Martin-Herranz; Cyrus R Safinya
Journal:  Adv Genet       Date:  2005       Impact factor: 1.944

10.  How does the spacer length of cationic gemini lipids influence the lipoplex formation with plasmid DNA? Physicochemical and biochemical characterizations and their relevance in gene therapy.

Authors:  Mónica Muñoz-Úbeda; Santosh K Misra; Ana L Barrán-Berdón; Sougata Datta; Clara Aicart-Ramos; Pablo Castro-Hartmann; Paturu Kondaiah; Elena Junquera; Santanu Bhattacharya; Emilio Aicart
Journal:  Biomacromolecules       Date:  2012-11-16       Impact factor: 6.988

View more
  4 in total

Review 1.  Engineering liposomal nanoparticles for targeted gene therapy.

Authors:  C Zylberberg; K Gaskill; S Pasley; S Matosevic
Journal:  Gene Ther       Date:  2017-05-15       Impact factor: 5.250

2.  Correlation of the cytotoxic effects of cationic lipids with their headgroups.

Authors:  Shaohui Cui; Yueying Wang; Yan Gong; Xiao Lin; Yinan Zhao; Defu Zhi; Quan Zhou; Shubiao Zhang
Journal:  Toxicol Res (Camb)       Date:  2018-03-22       Impact factor: 3.524

Review 3.  A critical overview of current progress for COVID-19: development of vaccines, antiviral drugs, and therapeutic antibodies.

Authors:  Monika Kumari; Ruei-Min Lu; Mu-Chun Li; Jhih-Liang Huang; Fu-Fei Hsu; Shih-Han Ko; Feng-Yi Ke; Shih-Chieh Su; Kang-Hao Liang; Joyce Pei-Yi Yuan; Hsiao-Ling Chiang; Cheng-Pu Sun; I-Jung Lee; Wen-Shan Li; Hsing-Pang Hsieh; Mi-Hua Tao; Han-Chung Wu
Journal:  J Biomed Sci       Date:  2022-09-12       Impact factor: 12.771

4.  Co-delivery of paclitaxel and anti-VEGF siRNA by tripeptide lipid nanoparticle to enhance the anti-tumor activity for lung cancer therapy.

Authors:  Chuanmin Zhang; Yinan Zhao; Enxia Zhang; Meilin Jiang; Defu Zhi; Huiying Chen; Shaohui Cui; Yuhong Zhen; Jingnan Cui; Shubiao Zhang
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.